Holen Sie sich die Stockscreener-App
0.9735
2.65%
-0.0265
Handel nachbörslich:
1.01
0.0365
+3.75%
Schlusskurs vom Vortag:
$1.00
Offen:
$0.99
24-Stunden-Volumen:
130.09K
Relative Volume:
0.90
Marktkapitalisierung:
$41.54M
Einnahmen:
$14.92M
Nettoeinkommen (Verlust:
$-86.88M
KGV:
-0.3171
EPS:
-3.0699
Netto-Cashflow:
$-82.31M
1W Leistung:
-2.44%
1M Leistung:
-0.83%
6M Leistung:
-40.28%
1J Leistung:
-67.55%
1-Tages-Spanne:
$0.96
$1.02
1-Wochen-Bereich:
$0.96
$1.09
52-Wochen-Spanne:
$0.80
$3.4179
Carisma Therapeutics Inc Stock (CARM) Company Profile
Firmenname
Carisma Therapeutics Inc
Sektor
Branche
Telefon
(267) 491-6422
Adresse
3675 MARKET STREET, PHILADELPHIA
Carisma Therapeutics Inc Stock (CARM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-06 | Eingeleitet | Evercore ISI | Outperform |
| 2023-05-31 | Hochstufung | Jefferies | Hold → Buy |
| 2023-05-24 | Eingeleitet | H.C. Wainwright | Buy |
| 2023-04-14 | Eingeleitet | Robert W. Baird | Outperform |
Carisma Therapeutics Inc Aktie (CARM) Neueste Nachrichten
Carisma shares climb on EF Hutton Buy rating - Investing.com India
Carisma Therapeutics names Sohanya Cheng to board - Investing.com India
Carisma Therapeutics Announces Changes to its Board of Directors - PR Newswire
Carisma Therapeutics Reports Second Quarter 2024 Financial Resul - GuruFocus.com
Carisma Therapeutics faces Nasdaq delisting over market value By Investing.com - Investing.com Australia
Carisma Therapeutics faces Nasdaq delisting over market value - Investing.com
Carisma Therapeutics to Showcase Cutting-Edge Cancer Research at SITC 2024 - MSN
Carisma Therapeutics Announces Upcoming Presentations at SITC 2024 - Yahoo Finance
Carly Rae Jepsen is engaged! Canadian singer shares happy news on social media: 'Very engaged over here' - Yahoo Canada Shine On
Carly Rae Jepsen Flaunts Blue Engagement Ring with Grammy Winning Fiancé - 2paragraphs Buzz
CRDF (Cardiff Oncology Inc) has impressive results - US Post News
Berkley W R Corp Sells 451,295 Shares of Cartica Acquisition Corp (NASDAQ:CITE) - MarketBeat
Carly Rae Jepsen is a fiancée! Singer announces engagement to Grammy-winning producer - USA TODAY
Carly Rae Jepsen Engaged to Producer Cole MGN: See Her RingE! Online - E! NEWS
'Very engaged over here': Singer Carly Rae Jepsen announces her engagement to music producer Cole M.G.N. - 9Honey Celebrity
Investing in Aclaris Therapeutics Inc (ACRS) Is Getting More Attractive - Knox Daily
Surprise! Carly Rae Jepsen Is Engaged!!! - PerezHilton.com
Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now - Benzinga
Carly Rae Jepsen announces engagement to boyfriend Cole MGN after two years of dating - Daily Mail
Carly Rae Jepsen Proclaims Herself ‘Very Engaged Over Here’ in Photoshoot Showing Off Ring From Fiancé Cole M.G.N. - Billboard
Carly Rae Jepsen Engaged to Producer Cole M.G.N. - AceShowbiz Media
Carly Rae Jepsen & Boyfriend Cole M.G.N. Are Engaged! - Just Jared
Cole M.G.N. Entertainment News, Photos, and Videos - Just Jared
A closer look at Cara Therapeutics Inc (CARA) is warranted - US Post News
Hancock Whitney Corp Has $737,000 Stock Holdings in Corcept Therapeutics Incorporated (NASDAQ:CORT) - Defense World
Where Are They Now? Carisma Therapeutics - Life Science Leader Magazine
Gabelli Funds LLC Has $120.74 Million Stake in Crane (NYSE:CR) - MarketBeat
Corbus Pharmaceuticals (NASDAQ:CRBP) PT Lowered to $40.00 at B. Riley - Defense World
Cosmic CRF shares hit 5% upper circuit on Rs 127-crore order win; details - Business Standard
Selling Buzz: Accuray Inc [ARAY] SVP Chief Financial Officer Pervaiz Ali sells 8,404 shares of the company - Knox Daily
A company insider recently sold 833 shares of Apollo Commercial Real Estate Finance Inc [ARI]. Should You Sale? - Knox Daily
Catalyst Pharmaceuticals (NASDAQ:CPRX) Hits New 1-Year High at $21.10 - MarketBeat
An analyst sees good growth prospects for Capricor Therapeutics Inc (CAPR) - SETE News
CMR Bolsters Funding for Mineral Exploration - TipRanks
Quest Partners LLC Purchases Shares of 934 Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) - Defense World
Mutual of America Capital Management LLC Increases Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) - MarketBeat
CRISM Therapeutics Reports Positive Interim Results - TipRanks
Cairn Homes Advances Share Buyback Plan - TipRanks
Cero Therapeutics postpones special stockholders meeting By Investing.com - Investing.com Canada
Federated Hermes Inc. Sells 134 Shares of Cimpress plc (NASDAQ:CMPR) - Defense World
Aclaris Therapeutics neutral rating reiterated on phase 2a trial - Investing.com
Federated Hermes Inc. Acquires 399,860 Shares of Costamare Inc. (NYSE:CMRE) - Defense World
Aclaris Therapeutics (NASDAQ:ACRS) Receives “Neutral” Rating from HC Wainwright - Defense World
Review: AfrAId (2024) - It's A Stampede!
BTIG Research gives a Neutral recommendation for Apollo Commercial Real Estate Finance Inc (ARI) - Knox Daily
Aclaris Therapeutics (NASDAQ:ACRS) Receives "Neutral" Rating from HC Wainwright - MarketBeat
What technical indicators reveal about CARA stock - US Post News
The time has not yet come to remove your chips from the table: Cara Therapeutics Inc (CARA) - SETE News
Cara Therapeutics Inc (CARA)’s Day in Review: Closing at 0.26, Down by -2.85 - The Dwinnex
Carisma Therapeutics and Moderna Expand Partnership to Target Autoimmune Diseases - MyChesCo
Carisma Therapeutics to Present at Upcoming Conferences - Kilgore News Herald
Finanzdaten der Carisma Therapeutics Inc-Aktie (CARM)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.11%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):